1-3 of 3
Virginie Dehame, MSc
Close
Sort by
Journal Articles

Immunotoxin Targeting Cell-Bound MUC1 on Myelomonocytic and Monocytic Leukemic Cells

Thierry Guillaume, MD PhD, Virginie Dehame, MSc, Patrice Chevallier, MD, Pierre Peterlin, MD, Marc Gregoire, PhD, Daniel Rubinstein, MD, Eddy Pichinuk, PhD, Daniel H Wreschner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5060.
https://doi.org/10.1182/blood.V130.Suppl_1.5060.5060
Published: 2017
Journal Articles

A Phase I/II Study of Vaccination By Autologous Leukemic Apoptotic Corpse Pulsed Dendritic Cells for Elderly Acute Myeloid Leukemia Patients in First or Second Complete Remission (LAM DC trial)

Patrice Chevallier, MD PhD, Soraya Saiagh, Virginie Dehame, MSc, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Yannick Le Bris, PharmD, Sylvain Bercegeay, Delphine Coulais, Marie-Aude Rambaud, Céline Bossard, MD, Veronique Stocco, MD, Brigitte Dreno, MD PhD, Nadine Juge-Morineau, MD, Philippe Moreau, Marie-Christine Bene, PharmD, Marc Gregoire, PhD
Journal: Blood
Blood (2016) 128 (22): 2821.
https://doi.org/10.1182/blood.V128.22.2821.2821
Published: 2016
Journal Articles

Targeting Cell-Bound MUC1 on Myelomonocytic and Monocytic Leukemias and Leukemic Stem Cells: Therapeutic Implications

Thierry Guillaume, MD PhD, Virginie Dehame, MSc, Patrice Chevallier, MD PhD, Pierre Peterlin, MD, Marc Grégoire, PhD, Philippe Moreau, Daniel B Rubinstein, MD, Eddy Pichinuk, PhD, Daniel H Wreschner, MD
Journal: Blood
Blood (2015) 126 (23): 2899.
https://doi.org/10.1182/blood.V126.23.2899.2899
Published: 2015